← Back to screener

Fortress Biotech, Inc. FBIO

Rank #2453 · Nasdaq · $0.2B market cap
Audited by KPMG LLP, no going-concern flag in the latest filing.
Score
16.9
P/E
-3.4
P/B
6.96
ROE
-202.3%
Op. Margin
-191.4%
Debt Ratio
642%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -3.4x, P/B 6.96x. Ranks in the top 82% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -202.3%. Ranks in the top 94% of the universe.

Safety ★☆☆☆☆
Poor

Debt ratio 642%. Ranks in the top 83% of the universe. Above 200% signals meaningful leverage risk.

Growth ★☆☆☆☆
Poor

Revenue decline of 31.8% year over year. Ranks in the top 95% of the universe.

Valuation is the relative strength (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$-0.0B$-0.0B$-0.0B–-1267
2012–$-0.0B$-0.0B$-0.0B–-3450
2013–$-0.0B$-0.0B$0.0B––
2014–$-0.0B$-0.0B$0.0B–101
2015–$-0.0B$-0.0B$0.1B–27
2016$0.0B$-0.0B$-0.0B$0.1B-2393.060
2017$0.0B$-0.1B$-0.0B$0.0B-5855.3228
2018$0.0B$-0.1B$-0.1B$0.1B-520.7239
2019$0.0B$-0.1B$-0.1B$0.0B-446.46547
2020$0.0B$-0.1B$-0.0B$0.0B-302.5587
2021$0.0B$-0.1B$-0.0B$0.1B-206.7136
2022$0.1B$-0.2B$-0.1B$0.1B-274.1157
2023$0.1B$-0.2B$-0.1B$0.0B-268.8585
2024$0.1B$-0.1B$-0.1B$0.0B-168.4736
2025$0.1B$-0.1B$-0.0B$0.0B-191.4642

← See the full screener